1,890
Views
1
CrossRef citations to date
0
Altmetric
Current Opinion

DIgestive COmplications in DIabetes – the DICODI population study

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 3-6 | Received 14 May 2022, Accepted 21 Jul 2022, Published online: 12 Aug 2022

References

  • Meldgaard T, Keller J, Olesen AE, et al. Pathophysiology and management of diabetic gastroenteropathy. Therap Adv Gastroenterol. 2019;12:1756284819852047.
  • BO-Thieme.pdf [Internet]. [cited 2022 Feb 14]. Available from: https://www.thieme.de/statics/dokumente/thieme/final/de/dokumente/corporate_thieme-gruppe/BO-Thieme.pdf.
  • Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 1958;48(4):797–812.
  • Abid S, Rizvi A, Jahan F, et al. Poor glycaemic control is the major factor associated with increased frequency of gastrointestinal symptoms in patients with diabetes mellitus. JPMA J Pak Med Assoc. 2007;57(7):345–349.
  • Almogbel RA, Alhussan FA, Alnasser SA, et al. Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes. Int J Health Sci. 2016;10(3):397–404.
  • Fujishiro M, Kushiyama A, Yamazaki H, et al. Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus. WJG. 2017;23(36):6694–6704.
  • Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16):1989–1996.
  • Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991;18(4):229–234.
  • Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1989;32(3):151–159.
  • Schvarcz E, Palmér M, Ingberg CM, et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med. 1996;13(5):478–481.
  • Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32(11):637–641.
  • Ko GT, Chan WB, Chan JC, et al. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus. Diabet Med J Br Diabet Assoc. 1999;16(8):670–674.
  • Ricci JA, Siddique R, Stewart WF, et al. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol. 2000;35(2):152–159.
  • Spångéus A, El-Salhy M, Suhr O, et al. Prevalence of gastrointestinal symptoms in young and Middle-aged diabetic patients. Scand J Gastroenterol. 1999;34(12):1196–1202.
  • Drewes VM. Mechanical and electrical activity in the duodenum of diabetics with and without diarrhea. Pressures, differential pressures and action potentials. Am J Dig Dis. 1971;16(7):628–634.
  • Whalen GE, Soergel KH, Geenen JE. Diabetic diarrhea. A clinical and pathophysiological study. Gastroenterology. 1969;56(6):1021–1032.
  • Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol. 1989;84(8):868–872.
  • de Boer SY, Masclee AA, Lamers CB. Effect of hyperglycemia on gastrointestinal and gallbladder motility. Scand J Gastroenterol Suppl. 1992;194:13–18.
  • Rayner CK, Verhagen MA, Hebbard GS, et al. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol. 2000;95(5):1175–1183.
  • Rayner CK, Samsom M, Jones KL, et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24(2):371–381.
  • Russo A, Sun WM, Sattawatthamrong Y, et al. Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects. Gut. 1997;41(4):494–499.
  • Concepción Zavaleta MJ, Gonzáles Yovera JG, Moreno Marreros DM, et al. Diabetic gastroenteropathy: an underdiagnosed complication. World J Diabetes. 2021;12(6):794–809.
  • Koletzko L, Macke L, Schulz C, et al. Helicobacter pylori eradication in dyspepsia: new evidence for symptomatic benefit. Best Pract Res Clin Gastroenterol. 2019;40–41:101637.
  • Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003;18(1):141–150.
  • Dimenäs E, Glise H, Hallerbäck B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30(11):1046–1052.
  • Elfström P, Sundström J, Ludvigsson JF. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther. 2014;40(10):1123–1132.
  • Kylökäs A, Kaukinen K, Huhtala H, et al. Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation. BMC Gastroenterol. 2016;16(1):76.
  • Haupt-Jorgensen M, Holm LJ, Josefsen K, et al. Possible prevention of diabetes with a gluten-FREE diet. Nutrients. 2018;10(11):1746.
  • Domínguez-Muñoz JE, D Hardt P, Lerch MM, et al. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62(5):1119–1130.